Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Buy LondonMetric Property (LMP) by Zaven Boyrazian in The Motley Fool
- Avoid Somero Enterprises Inc. (DI) (SOM) by Steve Moore in ShareProphets
- Avoid Intercede Group (IGP) by Steve Moore in ShareProphets
- Overweight Unite Group (UTG) by JP Morgan
- Buy European Green Transition (EGT) by Tom Winnifrith in ShareProphets
- Buy European Green Transition (EGT) by Steve Moore in ShareProphets
- Buy Spectra Systems Corporation (SPSY) by Hot Stock Rockets in ShareProphets
- Hold Robert Walters (RWA) by Deutsche Bank
- Buy Bodycote (BOY) by Jefferies
- Hold Bytes Technology Group (BYIT) by Jefferies
- Buy AstraZeneca (AZN) by Jefferies
- Buy AO World (AO.) by Jefferies
- Hold Unite Group (UTG) by Jefferies
- Buy Convatec Group (CTEC) by Jefferies
- Buy Wise Class A (WISE) by Jefferies
- Hold Whitbread (WTB) by Deutsche Bank
- Avoid Celebrus Technologies (CLBS) by Steve Moore in ShareProphets
- Neutral Tate & Lyle (TATE) by UBS
- Buy Wise Class A (WISE) by UBS
- Buy BAE Systems (BA.) by UBS
PureTech Health (PRTC) Share Price
Health Care Sector
NOTE: This is based on 146 open tips for PureTech Health (PRTC)
| Latest Bid : 121.80p | Latest Ask : 122.60p |
| High Today : 122.20p | Low Today : 119.20p |
| This Years High : 146.60p | This Years Low : 103.00p |
| Volume : 587,832 | MKT Cap : £290.15M |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
PureTech Health (PRTC) Overview
PureTech Health plc ("PureTech Health", "PureTech" or "the Company") is a clinical-stage biotherapeuticscompany dedicated to discovering, developing and commercializing highly differentiated medicines for
devastating diseases, including inflammatory, fibrotic and immunological conditions, intractable cancers,
lymphatic and gastrointestinal diseases and neurological and neuropsychological disorders, among others.
PureTech Health (PRTC) Latest Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Buy | Alex Ralph | Premium Only | 2025-04-10 19:20:00 10/04/2025 | 15.62% |
| Buy | Jefferies | Premium Only | 2024-12-16 15:01:00 16/12/2024 | -30.79% |
| Watch | Harvey Jones | Premium Only | 2024-08-21 13:55:00 21/08/2024 | – |
| Buy | Alan Oscroft | Premium Only | 2024-06-26 18:30:00 26/06/2024 | -37.49% |
| Avoid | Mark Tovey | Premium Only | 2024-01-08 12:10:00 08/01/2024 | 41.49% |
PureTech Health (PRTC) Active Short Positions
| Fund Manager | Position | Date |
|---|---|---|
| ActusRayPartners Limited | 0.6% | 31/03/2026 |
| Saba Capital Management, L.P. | 0.51% | 04/11/2025 |
| Latest Bid : 121.80p | Latest Ask : 122.60p |
| High Today : 122.20p | Low Today : 119.20p |
| This Years High : 146.60p | This Years Low : 103.00p |
| Volume : 587,832 | MKT Cap : £290.15M |
PureTech Health Overview
PureTech Health plc ("PureTech Health", "PureTech" or "the Company") is a clinical-stage biotherapeuticscompany dedicated to discovering, developing and commercializing highly differentiated medicines for
devastating diseases, including inflammatory, fibrotic and immunological conditions, intractable cancers,
lymphatic and gastrointestinal diseases and neurological and neuropsychological disorders, among others.
NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
Latest PureTech Health Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Buy | Alex Ralph | Premium Only | 2025-04-10 19:20:00 10/04/2025 | 15.62% |
| Buy | Jefferies | Premium Only | 2024-12-16 15:01:00 16/12/2024 | -30.79% |
| Watch | Harvey Jones | Premium Only | 2024-08-21 13:55:00 21/08/2024 | – |
| Buy | Alan Oscroft | Premium Only | 2024-06-26 18:30:00 26/06/2024 | -37.49% |
| Avoid | Mark Tovey | Premium Only | 2024-01-08 12:10:00 08/01/2024 | 41.49% |